UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 30, 2026
Sale
Calculated transaction value
$653.46K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 29, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$593.54
Oct 29, 2026
First close after public filing
$596.13
Nov 2, 2026
Return after filing · so far
-5.72%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,104 shares @ $591.9
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000175
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.77M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $808.75K |
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $23.97K |
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $31.29K |
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $742.43K |
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $926.81K |
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $914.57K |
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $999.89K |
| United Therapeutics Corp UTHR | Sale | Oct 29, 2026 | $549.25K |
| United Therapeutics Corp UTHR | Exercise | Oct 29, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Oct 29, 2026 | $1.12M |
| United Therapeutics Corp UTHR Current | Sale | Oct 29, 2026 | $653.46K |